Visionaire Health Economics Study Comparing Economic Outcomes Between Visionaire and Standard Instrumentation

NCT ID: NCT02158819

Last Updated: 2019-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

52 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-07-09

Study Completion Date

2017-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose and primary objective of this study is to compare health economic outcomes between the use of a patient-matched cutting guide (Visionaire) versus the use of standard instrumentation in Total Knee Arthroplasty(TKA). Data will be collected pre-operatively, intra-operatively and post operatively up until and including the six week post-operative assessment. The secondary objectives of the study are to compare safety and early readmission rates between the two techniques. The study hypothesis is that there is no difference in the cost of the episode of care from hospital admission to discharge, including pre-operative radiology costs and cost of resources, with the Visonaire patient-matched cutting guide compared to standard instrumentation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, randomised pilot study comparing the health economic outcomes between TKA using standard instrumentation and TKA using a patient-matched cutting guide. The primary indication for this study is degenerative arthritis of the knee requiring unilateral primary total knee arthroplasty. Patients requiring TKA who are eligible and have consented to participate will be randomised to TKA with The Genesis II™ Total Knee Implant System or the Legion™ Primary Total Knee System using either Visionaire™ patient-matched cutting guides or standard instrumentation. The study will recruit for 1 year and patients will have a final follow up at the six week post-operative assessment.

The primary objective of this study will evaluate the cost of the episode of care from hospital admission to discharge. This will include pre-operative costs, anesthetic costs, operative and theatre costs, costs of instruments and resources. The study will also measure length of stay as well as blood transfusion requirements. The secondary objectives of this study are to compare the safety and early readmission rates between the two techniques, by measuring the complication rates intra-operatively and post-operatively as well as the number of patients readmitted to hospital prior to the six week post-operative assessment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis, Knee

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TKA with standard instrumentation

This arm consists of the Genesis II Total knee implant system or the Legion Primary total knee system with standard instrumentation

Group Type NO_INTERVENTION

No interventions assigned to this group

Total knee arthroplasty with Visionaire

This arm will consist of the Genesis II Total Knee Implant System or Legion Primary Total Knee System with the Visionaire patient-matched instrumentation

Group Type ACTIVE_COMPARATOR

Total knee arthroplasty with Visionaire

Intervention Type DEVICE

Patient Specific Instrumentation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Total knee arthroplasty with Visionaire

Patient Specific Instrumentation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Degenerative arthritis of the knee requiring unilateral primary Total Knee Arthroplasty in subjects for whom the use of patient-matched cutting guides or standard instrumentation are, in the surgeon's opinion, clinically appropriate and acceptable forms of treatment;
* Patient is of legal age to consent and is skeletally mature;
* The patient is able to fully understand the purpose of the trial, and his/her role as a participant in the study
* The patient consents to his/her inclusion in the study after the nature, scope and possible consequences of the study have been explained in an understandable form.

Exclusion Criteria

* Patient is known to have poor bone stock making a Total Knee Arthroplasty unjustifiable.
* Patient is immuno-suppressed.
* Patient has physical, emotional or neurological conditions that would compromise the subject's compliance with postoperative rehabilitation and follow-up.
* Patient is pregnant or may become pregnant during the course of the study, or is lactating.
* Patient has a history of prior ipsilateral major knee surgery (e.g. arthroplasty, high tibial osteotomy, or tibial plateau fracture). Minor prior procedures such as Anterior Cruciate Ligament repair, meniscectomy, or arthroscopy are not excluded.
* Patient has active, localized or systemic infection.
* Patient is severely overweight (BMI \>40).
* Patient is a prisoner.
* Patient has a significant MRI (magnetic resonance imaging) exclusion or contraindication.
* Patient has had a total joint arthroplasty of the contralateral limb in the last 12 months.
* Patient presently identified with future need for bilateral TKA within the next twenty-four months.
* Patient has a known or suspected hypersensitivity/allergy to foreign materials contained in the implant
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Smith & Nephew, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andrew Baker

Role: PRINCIPAL_INVESTIGATOR

Private Practice

Lieth Stewart

Role: PRINCIPAL_INVESTIGATOR

Life Claremont Hospital

Willem Tollig

Role: PRINCIPAL_INVESTIGATOR

Pretoria East Hospital

Michael Barrow

Role: PRINCIPAL_INVESTIGATOR

Sunninghill Hospital

Dan Potgieter

Role: PRINCIPAL_INVESTIGATOR

Life Bay View Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Life Bay View Hospital

Mossel Bay, Cape Town, South Africa

Site Status

Sunninghill Hospital

Johannesburg, Gauteng, South Africa

Site Status

Pretoria East Hospital

Pretoria, Gauteng, South Africa

Site Status

Private Practice

Durban, KwaZulu-Natal, South Africa

Site Status

Life Claremont Hospital

Cape Town, Western Cape, South Africa

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Africa

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VISHE.13

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.